Immunophenotyping of SARS-CoV-2 and vaccine design
Author:
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccinationCell Reports, 2021
- Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York CityOpen Forum Infectious Diseases, 2021
- Complicating Infections Associated with Common Endemic Human Respiratory CoronavirusesHealth Security, 2021
- Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19SN Comprehensive Clinical Medicine, 2020
- A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline CoronavirusesViruses, 2020
- Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi ArabiaJournal of Clinical Microbiology, 2015
- The Evolutionary Processes of Canine CoronavirusesAdvances in Virology, 2011
- Vaccines to prevent severe acute respiratory syndrome coronavirus-induced diseaseVirus Research, 2008
- Development and use of the H strain of avian infectious bronchitis virus from the Netherlands as a vaccine: a reviewAvian Pathology, 2004
- Bovine coronaviruses associated with enteric and respiratory diseases in Canadian dairy cattle display different reactivities to anti-HE monoclonal antibodies and distinct amino acid changes in their HE, S and ns4.9 proteinVirus Research, 2001